Merck & Co., Inc.MRK
NYSE•Healthcare•Drug Manufacturers - General
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $65.59B, growing 2.5% year-over-year. TTM net income stood at $8.94B (48.7% contraction). Quarterly EBITDA was $-1.88B and operating income was $-1.88B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze MRK growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters